483 Merck Sharp & Dohme Apr 2004

483 Merck Sharp & Dohme Apr 2004

Ann Montemurro FDA, Paula Trost FDA$119.00 - Available Now

FDA investigators audited the Merck Sharp & Dohme - West Point, PA, United States facility and issued inspectional observations (via FDA 483) on 22 Apr 2004.

Product details

  • Category: Biologics / Human Drugs
  • Inspection end: 22 Apr 2004
  • Location: West Point, United States
  • FEI: 2510592
Add To Cart